LightPath Technologies
LPTH
#6808
Rank
S$0.80 B
Marketcap
S$13.93
Share price
5.98%
Change (1 day)
430.84%
Change (1 year)

LightPath Technologies - 10-Q quarterly report FY


Text size:
================================================================================
U. S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2001

OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ____________


COMMISSION FILE NUMBER 000-27548


LIGHTPATH TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)


DELAWARE 86-0708398
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)

3819 OSUNA, N.E. HTTP://WWW.LIGHTPATH.COM 87109
ALBUQUERQUE, NEW MEXICO (ZIP Code)
(Address of principal executive offices)


Registrant's telephone number, including area code:
(505) 342-1100

Check whether the registrant (1) filed all reports required to be filed by
Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days. YES [X] NO [ ]

Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practical date:

Common Stock, Class A, $.01 par value 19,478,667 shares
CLASS OUTSTANDING AT JANUARY 30, 2002

================================================================================
LIGHTPATH TECHNOLOGIES, INC.
FORM 10-Q

INDEX

ITEM PAGE
- ---- ----

PART I FINANCIAL INFORMATION

Item 1 Condensed Consolidated Balance Sheets 2
Condensed Consolidated Statements of Operations 3
Condensed Consolidated Statements of Cash Flows 4
Notes to Condensed Consolidated Financial Statements 5
Item 2 Management's Discussion and Analysis of Financial
Condition and Results of Operations 12
Item 3 Quantitative and Qualitative Disclosures About Market Risk 19


PART II OTHER INFORMATION

Legal Proceedings 20
Changes in Securities and Use of Proceeds 21
Defaults Upon Senior Securities 21
Submission of Matters to a Vote of Security Holders 21
Other Information 21
Exhibits and Reports on Form 8-K 21

SIGNATURES 22

1
LIGHTPATH TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)

<TABLE>
<CAPTION>
DECEMBER 31, JUNE 30,
2001 2001
------------- -------------
<S> <C> <C>
ASSETS
Current assets:
Cash and cash equivalents $ 20,777,024 $ 29,273,034
Trade accounts receivable - less allowance of $183,413 and $120,947 1,937,183 2,579,483
Inventories 3,984,708 5,414,587
Prepaid expenses and other receivables 659,174 1,058,187
------------- -------------
Total current assets 27,358,089 38,325,291

Property and equipment - net 11,699,853 12,046,891
Intangible assets - net 10,908,448 25,683,341
Investment in LightChip, Inc. and other assets 8,440,065 8,234,885
------------- -------------
Total assets $ 58,406,455 $ 84,290,408
============= =============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 789,855 $ 1,276,204
Accrued liabilities 1,504,972 300,263
Accrued payroll and benefits 946,666 1,131,252
Current portion of capital lease obligations 116,654 242,475
------------- -------------
Total current liabilities 3,358,147 2,950,194

Deferred income taxes -- 3,316,304
Redeemable convertible preferred stock - see note 6 1,465,086 1,417,070

Commitments and contingencies

Stockholders' equity
Common stock: Class A, $.01 par value, voting;
34,500,000 shares authorized; 19,478,667 and 19,371,167 shares
issued and outstanding 194,787 193,712
Additional paid-in capital 186,705,752 181,708,752
Accumulated deficit (133,317,317) (105,295,624)
------------- -------------
Total stockholders' equity 53,583,222 76,606,840
------------- -------------
Total liabilities and stockholders' equity $ 58,406,455 $ 84,290,408
============= =============
</TABLE>

SEE ACCOMPANYING NOTES.

2
LIGHTPATH TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

<TABLE>
<CAPTION>
THREE MONTHS ENDED SIX MONTHS ENDED
DECEMBER 31, DECEMBER 31,

2001 2000 2001 2000
------------ ------------ ------------ ------------
<S> <C> <C> <C> <C>
REVENUES

Telecom product and lens sales $ 2,325,704 $ 7,757,106 $ 5,675,758 $ 10,654,675

Product development fees and other sales 71,167 3,500 179,159 170,870
------------ ------------ ------------ ------------
Total revenues 2,396,871 7,760,606 5,854,917 10,825,545

COSTS AND EXPENSES

Cost of sales (exclusive of stock-based compensation
of $6,956, none, $13,912 and none, for the three
months ended December 31, 2001 and 2000, and the
six months ended December 31, 2001 and 2000,
respectively) 3,804,654 4,711,487 6,918,421 6,436,261

Selling, general and administrative (exclusive of stock-
based compensation of $1,869,294, $2,782,773,
$4,678,346 and $5,482,773 for the three months
ended December 31, 2001 and 2000, and the six
months ended December 31, 2001 and 2000,
respectively) 2,888,398 4,275,338 6,725,666 7,683,828

Research and development (exclusive of stock-based
compensation of none, none, $13,767 and none for
the three months ended December 31, 2001 and
2000, and the six months ended December 31, 2001 and
2000, respectively) 2,169,419 1,768,900 4,221,873 3,131,243

Impairment of long-lived and intangible assets 6,955,229 -- 6,955,229 --

Stock-based compensation 1,876,250 2,782,773 4,706,025 5,482,773

Amortization of goodwill and intangibles 2,410,063 3,676,212 5,100,819 6,214,342

Acquired in process research and development -- -- -- 9,100,000
------------ ------------ ------------ ------------
Total costs and expenses 20,104,013 17,214,710 34,628,033 38,048,447
------------ ------------ ------------ ------------
Operating loss (17,707,142) (9,454,104) (28,773,116) (27,222,902)

OTHER INCOME (EXPENSE)

Investment and other income, net 89,716 609,143 799,439 1,439,208
------------ ------------ ------------ ------------
Net loss $(17,617,426) $ (8,844,961) $(27,973,677) $(25,783,694)

Imputed dividend on preferred stock (22,407) (18,551) (48,016) (45,464)
------------ ------------ ------------ ------------
Net loss applicable to common shareholders $(17,639,833) $ (8,863,512) $(28,021,693) $(25,829,158)
============ ============ ============ ============
Basic and diluted net loss per share $ (0.91) $ (0.46) $ (1.45) $ (1.38)
============ ============ ============ ============
Number of shares used in per share calculation 19,392,308 19,242,857 19,381,738 18,785,241
============ ============ ============ ============
</TABLE>

SEE ACCOMPANYING NOTES.

3
LIGHTPATH TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)

<TABLE>
<CAPTION>
SIX MONTHS ENDED
DECEMBER 31,
2001 2000
------------ ------------
<S> <C> <C>
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss $(27,973,677) $(25,783,694)
Adjustments to reconcile net loss to net cash used in
operating activities:
Depreciation and amortization 6,579,098 7,343,661
Impairment of long-lived and intangible assets 6,955,229 --
Stock-based compensation 4,706,025 5,482,773
Acquired in process research and development -- 9,100,000
Changes in operating assets and liabilities (net of the
effect of the acquisition of Geltech, Inc.):
Trade receivables 642,300 (3,192,176)
Inventories 1,429,879 (1,721,669)
Prepaid expenses and other 453,013 (153,655)
Accounts payable and accrued expenses 533,774 (647,184)
------------ ------------
Net cash used in operating activities (6,674,359) (9,571,944)

CASH FLOWS FROM INVESTING ACTIVITIES
Property and equipment additions, net (2,315,255) (3,968,052)
Proceeds from sale of assets 372,480 --
Patent and license agreement costs (45,105) (33,550)
Acquisition of Geltech, Inc., net of cash acquired -- (18,411)
Investment in LightChip -- (7,234,885)
------------ ------------
Net cash used in investing activities (1,987,880) (11,254,898)

CASH FLOWS FROM FINANCING ACTIVITIES
Payments on capital leases (125,821) (797,561)
Proceeds from exercise of stock options and warrants 292,050 1,143,351
------------ ------------
Net cash provided by financing activities 166,229 345,790
------------ ------------
Net decrease in cash and cash equivalents (8,496,010) (20,481,052)
Cash and cash equivalents at beginning of period 29,273,034 58,728,130
------------ ------------
Cash and cash equivalents at end of period $ 20,777,024 $ 38,247,078
============ ============

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Class A common stock, warrant and stock options
issued to acquire Geltech, Inc. $ -- $ 27,723,054
Note receivable in exchange for equipment $ 270,000 $ --
Class E common stock issued $ -- $ 556
Class E common stock redemption $ -- $ 40,221
============ ============
</TABLE>

SEE ACCOMPANYING NOTES.

4
LIGHTPATH TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED
DECEMBER 31, 2001

ORGANIZATION

LightPath Technologies, Inc. ("LightPath" or the "Company") was incorporated in
Delaware on June 15, 1992. On April 14, 2000, the Company acquired Horizon
Photonics, Inc. ("Horizon"). On September 20, 2000, the Company acquired
Geltech, Inc. ("Geltech"). The Company is engaged in the production of
collimator, isolator, and precision molded aspherical optics used in the telecom
components market, GRADIUM(R) glass lenses and other optical materials.
Additionally, Geltech has a unique and proprietary line of all-glass diffraction
gratings (StableSil(R)) for telecom applications as well as a product family of
Sol-Gel based waveguides. The Company also performs research and development for
optical solutions for the fiber telecommunications and traditional optics
markets. As used herein, the terms ("LightPath" or the "Company"), refer to
LightPath individually or, as the context requires, collectively with its
subsidiaries on a consolidated basis.

BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been
prepared in accordance with the requirements of Article 10 of Regulation S-X
and, therefore, do not include all information and footnotes necessary for a
fair presentation of financial position, results of operations, and cash flows
in conformity with generally accepted accounting principles. These consolidated
financial statements should be read in conjunction with the Company's
consolidated financial statements and related notes included in its Form 10-KSB
for the fiscal year ended June 30, 2001, as filed with the Securities and
Exchange Commission on August 29, 2001.

These statements are unaudited but include all adjustments, which include normal
recurring adjustments, that the Company considers necessary to present fairly
the financial position, results of operations and cash flows of the Company for
the interim periods presented. Results of operations for interim periods are not
necessarily indicative of results which may be expected for the year as a whole.

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

CONSOLIDATED FINANCIAL STATEMENTS include the accounts of the Company and its
wholly-owned subsidiaries. All significant intercompany transactions have been
eliminated in consolidation.

CASH AND CASH EQUIVALENTS consist of cash in the bank and temporary investments
with maturities of ninety days or less when purchased.

INVENTORIES which consists principally of raw materials, lenses, isolators,
collimators and components are stated at the lower of cost or market, on a
first-in, first-out basis. Inventory costs include materials, labor and
manufacturing overhead.

PROPERTY AND EQUIPMENT are stated at cost and depreciated using both
straight-line and accelerated methods over the estimated useful lives of the
related assets ranging from three to seven years. Platinum molds less estimated
salvage value are depreciated on a straight-line basis over the estimated useful
lives ranging from one to two years.

INTANGIBLE ASSETS consisting of goodwill, customer list and supply contracts,
licenses, patents, trademarks and others are recorded at cost. Upon issuance of
the license, patent or trademark, these assets are being amortized on the
straight-line basis over the estimated useful lives of the related assets
ranging from ten to seventeen years. Goodwill, customer list and supply
contracts and other intangibles are being amortized on straight-line basis over
the estimated period of benefit ranging from two to eight years. The
recoverability of the carrying values of these intangible assets are evaluated
on a recurring basis.

5
LIGHTPATH TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED


INVESTMENTS consists of the Company's ownership interest in LightChip Inc.
(LightChip) which is accounted for under the cost method.

INCOME TAXES are accounted for under the asset and liability method. Deferred
income tax assets and liabilities are computed for differences between the
financial statement and tax bases of assets and liabilities that will result in
taxable or deductible amounts in the future based upon enacted tax laws and
rates applicable to the periods in which the differences are expected to affect
taxable income. Valuation allowances are established when necessary to reduce
deferred tax assets to the amount expected to be realized.

REVENUE is generally recognized from product sales when products are shipped to
the customer provided that LightPath has received a valid purchase order, the
price is fixed, title has transferred, collection of the associated receivable
is reasonably assured, and there are no remaining significant obligations.
Revenues from product development agreements are recognized as milestones are
completed in accordance with the terms of the agreements. Provisions for
estimated losses are made in the period in which such losses are determined.

RESEARCH AND DEVELOPMENT costs are expensed as incurred.

STOCK-BASED COMPENSATION is accounted for using the intrinsic value method as
prescribed by APB Opinion No. 25, ACCOUNTING FOR STOCK ISSUED TO EMPLOYEES,
under which no compensation expense is recognized when the exercise price of the
employees stock option equals or exceeds the market price of the underlying
stock on the date of grant and other requirements are met. For stock options
granted to non-employees, stock-based compensation is determined using the fair
value method as prescribed by SFAS 123, "Accounting for Stock-Based
Compensation."

MANAGEMENT MAKES ESTIMATES and assumptions during the preparation of the
Company's consolidated financial statements that affect amounts reported in the
financial statements and accompanying notes. Such estimates and assumptions
could change in the future as more information becomes known, which in turn
could impact the amounts reported and disclosed herein.

FAIR VALUES OF FINANCIAL INSTRUMENTS of the Company are disclosed as required by
Statement of Financial Accounting Standards No. 107, DISCLOSURES ABOUT FAIR
VALUES OF FINANCIAL INSTRUMENTS. The carrying amounts of cash and cash
equivalents, trade accounts receivable, accounts payable and accrued liabilities
approximate fair value.

LONG-LIVED ASSETS are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of the assets may not be
recoverable. When an evaluation is required, the estimated future undiscounted
cash flows associated with the asset are compared to the asset's carrying amount
to determine if a write-down to fair value is required. See Notes 3 and 4.

2. INVENTORIES

The components of inventories include the following at:

December 31 June 30
2001 2001
----------- -----------
Raw materials $ 2,525,626 $ 3,208,838
Work in process 460,473 971,916
Finished goods 998,609 1,233,833
----------- -----------
Total inventories $ 3,984,708 $ 5,414,587
=========== ===========

6
LIGHTPATH TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED


3. PROPERTY AND EQUIPMENT

During the second quarter of fiscal 2002, the Company recorded an impairment
charge to write off certain excess manufacturing equipment with a carrying value
of approximately $553,000 which was used in the production of collimators and
was removed from service by the Company due to changes in the manufacturing
process.

4. INTANGIBLE ASSETS

Intangible assets consist of the following:

Life December 31 June 30
In years 2001 2001
-------- ----------- -----------
Goodwill 4 $ 5,203,365 $ 5,203,365
Customer list and supply contract 4 1,041,750 4,800,000
Developed technology 2 - 4 6,064,981 18,000,000
Covenant not-to-compete 3 3,100,000 3,100,000
Other intangibles 2 - 5 2,860,000 2,860,000
Patents and trademarks granted 10 - 17 602,673 582,787
License agreements 17 46,560 46,560
Patent applications in process 146,539 127,800
----------- -----------
19,065,868 34,720,512
Less accumulated amortization 8,157,420 9,037,171
----------- -----------
Total intangible assets $10,908,448 $25,683,341
=========== ===========

Pursuant to SFAS No. 121, "Accounting for the Impairment of Long-Lived Assets
and for Long-Lived Assets to be Disposed of," the Company evaluated the
recoverability of its the long-lived assets as of December 31, 2001, including
the intangible assets acquired in April 2000 and September 2000, when the
Company purchased Horizon Photonics, Inc. ("Horizon") and Geltech Inc.
("Geltech"), respectively. While revenues from the sale of Horizon's products
was substantial during fiscal 2001, Horizon has had to defer sales under a
supply contract to a significant customer since May 2001. At June 30, 2001, the
Company determined that the estimated future undiscounted cash flows related to
the customer supply contract and associated goodwill recorded in connection with
the acquisition of Horizon were below the carrying value of the related
intangible assets and the intangibles were written down to their estimated fair
value at June 30, 2001. In November 2001, the customer indicated they will not
take delivery of any remaining orders which resulted in the impairment of the
remaining carrying value of the customer supply contract of approximately $1.5
million as of December 31, 2001. In addition, Geltech continued to experience
sales growth during the first quarter of fiscal 2002, however, design changes by
a major customer in October 2001 as well as the continued decline in the
telecommications industry has lead to a significant decline in future sales
projections and growth potential at Geltech. At December 31, 2001, the Company
determined that the estimated future undiscounted cash flows remaining from the
developed technology and customer list recorded in connection with the purchase
of Geltech were below the carrying value of the related intangible assets.
Accordingly, the Company recorded an impairment charge of approximately $4.9
million to write down the carrying value of these intangibles to their estimated
fair value of approximately $4.7 million at December 31, 2001. The estimated
fair values of the intangible assets were based on the anticipated discounted
future cash flows from revised sales forecasts. In addition, the Company
reversed the net deferred tax liability of approximately $3.3 million
established in connection with the non-taxable purchase of Geltech against the
related intangible assets prior to the impairment charge as the carrying value
of the remaining Geltech intangible assets was reduced in connection with the
impairment.

5. ACQUISITIONS

On September 20, 2000, the Company acquired all of the outstanding shares of
Geltech, a leading manufacturer of precision molded aspherical optics used in
the active telecom components market to provide a highly efficient means to
couple laser diodes to fibers or waveguides. Additionally, Geltech has a unique
and proprietary line of all-glass diffraction gratings (StableSil(R)) for

7
LIGHTPATH TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED


telecom applications such as optical switching, mux/demux and laser tuning as
well as a product family of Sol-Gel based waveguides. LightPath acquired all of
the outstanding shares of Geltech for 822,737 shares of Class A common stock
(valued at $27.5 million) which resulted an aggregate purchase price of $28.5
million including acquisition costs. The acquisition has been accounted for
using the purchase method of accounting and, accordingly, the results of
operations of Geltech have been included in the Company's consolidated financial
statements from September 20, 2000. In the first quarter of fiscal 2001, the
Company recorded an immediate non-recurring charge of $9.1 million, due to
acquired in-process research and development based on an assessment of purchased
technology of Geltech.

6. REDEEMABLE CONVERTIBLE PREFERRED STOCK

The Series F Convertible Preferred Stock has a stated value and liquidation
preference of $10,000 per share, plus a 7% per annum premium. The holders of the
Series F Convertible Preferred Stock are not entitled to vote or to receive
dividends. Each share of Series F Convertible Preferred Stock is convertible at
the option of the holder, into Class A common stock based on its stated value at
the conversion date divided by a conversion price. The conversion price is
defined as the lesser of $5.00 or 80% of the average closing bid price of the
Company's Class A common stock for the five days preceding the conversion date.
The Company accounted for the beneficial conversion feature associated with the
Series F Convertible Preferred Stock at issuance.

The certificate of designation of the Series F Convertible Preferred Stock
provides the Company the right to convert any outstanding shares to Class A
common stock or redeem them for cash three years from the date of issuance
(effective November 2002). In addition, the certificate of designation provides
that In the event of any liquidation, dissolution or winding up of the Company
("Liquidation Event"), either voluntary or involuntary, the then Holders of
shares of Series F Preferred Stock shall be entitled to receive an amount per
share equal to the sum of (i) the Original Series F Issue Price for each
outstanding share of Series F Preferred Stock and (ii) an amount equal to seven
percent (7%) of the Original Series F Issue Price, per annum. At each Holder's
option, a sale, conveyance or disposition of all or substantially all of the
assets of the Company or the effectuation by the Company of a transaction or
series of related transactions in which more than fifty percent (50%) of the
voting power of the Company is disposed of shall be deemed to be a Liquidation
Event as defined above. A consolidation, merger, acquisition, or other business
combination of the Company with or into any other publicly traded company or
companies shall not be treated as a Liquidation Event as defined above, however,
a consolidation, merger, acquisition, or other business combination of the
Company with or into any other non-publicly traded company or companies in which
the surviving entity is not a publicly traded company shall be treated as a
Liquidation Event as defined above.

Based on the SEC staff guidance addressed in EITF Topic D-98, which indicates
that the possibility that any triggering event that is not solely within the
control of the issuer could occur - without regard to probability - requires the
security to be classified outside of permanent equity, the Company has
classified the Series F preferred stock outside of stockholders' equity, for all
periods presented.

7. STOCKHOLDERS' EQUITY

The Company's authorized common stock includes, 2,000,000 shares of Class E-1
common stock, 2,000,000 shares of Class E-2 common stock and 1,500,000 shares of
Class E-3 common stock (collectively the "E Shares") with $.01 par value. The E
Shares were automatically convertible into Class A common stock upon the
attainment of certain conversion provisions through June 30, 2000. Since the
conversion provisions expired without being met, the E Shares were redeemed by
the Company, effective as of December 30, 2000. The holders of E Shares will
receive their redemption value of $.0001 per share upon resolution of certain
stockholder litigation relating to E Shares. See Note 10.

<TABLE>
<CAPTION>
Class A Warrants
Common Class C, E, L, Common Stock
Stock and other Options
----------- -------------- ------------
<S> <C> <C> <C>
Shares outstanding at June 30, 2001 19,371,167 299,300 4,249,454

Options granted -- -- 358,745
Options exercised 107,500 -- (107,500)
Option forfeitures -- -- (318,458)
----------- -------- ----------
Shares outstanding at December 31, 2001 19,478,667 299,300 4,182,241
=========== ======== ==========
</TABLE>

8
LIGHTPATH TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED


8. NET LOSS PER SHARE

Basic net loss per common share is computed based upon the weighted average
number of shares of Class A common stock outstanding during each period
presented. The computation of Diluted net loss per common share does not differ
from the basic computation because potentially issuable securities would be
anti-dilutive. The following outstanding securities were not included in the
computation of diluted earnings per share at December 31, 2001: 4,182,241 shares
of Class A common stock issuable upon exercise of outstanding stock options,
299,300 shares of Class A common stock issuable upon exercise of private
placement and other warrants, and 541,092 shares of Class A common stock
issuable upon the conversion of convertible preferred stock (292,483 shares
based on the fixed conversion price at closing). A seven percent premium earned
by the preferred shareholders increased the net loss applicable to common
shareholders by $22,407 and $18,551 for the three months ended December 31, 2001
and 2000, respectively, and by $48,016 and $45,464 for the six months ended
December 31, 2001 and 2000, respectively.

9. SEGMENT INFORMATION

Optoelectronics and Fiber Telecommunications ("Telecom") and Traditional Optics
are the Company's reportable segments under SFAS No. 131, "Disclosure about
Segments of an Enterprise and Related Information". For the six months ended
December 31, 2001, Telecom product sales represent approximately 60% of total
revenues and Traditional Optics sales represent approximately 40% of total
revenues of the Company. The telecom segment is based primarily on the
development and sale of fiber collimators and fiber-optic switches, free space
isolators, precision molded aspheric optics and other related passive component
products for the optoelectronics segment of the telecommunications industry. The
traditional optics segment is based primarily upon the sale of lenses to the
data storage and medical equipment market and the development and sale of
GRADIUM glass in the form of lenses and blanks for the general optics markets.

Summarized financial information concerning the Company's reportable segments
for the six and three months ended December 31, is shown in the following table.

<TABLE>
<CAPTION>
Traditional Corporate
Telecom Optics and Other (1) Total
------- ------ ------------- -----
<S> <C> <C> <C> <C>
SIX MONTHS ENDED
DECEMBER 31

Revenues (2)

2001 $ 3,544,155 2,310,762 -- $ 5,854,917

2000 $ 8,643,480 2,182,065 -- $ 10,825,545

Segment operating loss (3)

2001 $(6,220,057) (1,793,727) (20,759,332) $(28,773,116)

2000 $(3,429,433) (41,966) (23,751,503) $(27,222,902)
</TABLE>

(continued)

9
LIGHTPATH TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED


<TABLE>
<CAPTION>
Traditional Corporate
continued Telecom Optics and Other (1) Total
------- ------ ------------- -----
<S> <C> <C> <C> <C>
THREE MONTHS ENDED
DECEMBER 31

Revenues (2)

2001 $ 1,474,768 922,103 -- $ 2,396,871

2000 $ 5,828,224 1,932,382 -- $ 7,760,606

Segment operating loss (3)

2001 $(3,727,435) (1,066,997) (12,912,710) $(17,707,142)

2000 $(1,604,472) 275,081 (8,124,713) $ (9,454,104)
</TABLE>

(1) Corporate functions include certain members of executive management, the
corporate accounting and finance function, non-cash charges and other
typical administrative functions which are not allocated to segments.
(2) There were no material inter-segment sales during all periods presented.
(3) In addition to unallocated corporate functions, management does not
allocate interest expense, interest income, and other non-operating income
and expense amounts in the determination of the operating performance of
the reportable segments.

10. CONTINGENCIES

On May 2, 2000, the Company commenced a class action lawsuit in the Chancery
Court of Delaware, New Castle County. The action seeks a declaratory judgment
with respect to the Company's right to redeem the Class E Common Stock on
December 30, 2000 for $.0001 per share, the right of the holders of Class E
Common Stock to vote at the Annual Meeting held on October 6, 2000, and for
certification of the holders of Class E Common Stock as a class and the named
defendants as its representatives. The named defendants are Donald E. Lawson,
former President, Chief Executive Officer and Director of the Company, who owns
an aggregate of 25,000 shares of Class E Common Stock, Louis G. Leeburg, a
Director of the Company, who owns an aggregate of 7,272 shares of Class E Common
Stock, and William Leeburg, who owns or controls an aggregate of 21,816 shares
of Class E Common Stock. The Company proposed a settlement of this lawsuit which
the Delaware Chancery Court heard on January 8, 2001. The settlement proposal
was made to include all holders of Class E Common Stock. On February 2, 2001,
the Delaware Chancery Court issued a letter in which it indicated that holders
of Class E Common Stock must be provided an opportunity to request exclusion
from the settlement class. The Company has re-evaluated the proposed settlement
offer and in December 2001 determined it will proceed with the settlement to
include a provision that each E shareholder has the right to request exclusion
from the settlement class. The final settlement terms allow the holders of Class
E Common Stock to elect to receive either $0.40 for each share of Class E Common
Stock or receive an option to purchase five shares of Class A Common Stock for
each 100 shares of Class E Common Stock they hold for a period of two years with
an exercise price of $3.73 per share. The Company estimates that if all of the
Class E Common Stock were exchanged for options, approximately 40,220 options to
acquire 201,102 shares of Class A Common Stock would be issued resulting in a
settlement charge equal to the estimated fair value of the options issued of
approximately $458,000. If all of the Class E Common Stock were exchanged for
cash, a settlement charge of approximately $1.6 million would be recorded. The
Company has determined that it is probable that the settlement offer will occur
and an estimated settlement charge of $1.1 million has been accrued as of
December 31, 2001.

On or about June 9, 2000, a small group of holders of Class E Common Stock (the
"Texas Plaintiffs") commenced an action in a state court in Texas (the "Texas
Action"). The Texas Plaintiffs allege that the actions of the Company, and
certain named individuals, leading up to and surrounding the Company's 1995
proxy statement constitute fraud, negligent misrepresentation, fraudulent
inducement, breach of fiduciary duty and civil conspiracy. In general, the Texas
Plaintiffs allege misrepresentations and omissions in connection with a request
from the Company that its shareholders consent to a recapitalization, resulting
in a 5.5 to 1 reverse stock split and the issuance of certain Class E Common
Stock. The Texas Plaintiffs further allege that, as a result of the defendants'

10
LIGHTPATH TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED


actions, they were induced to consent to the Company's recapitalization. The
Company believes the allegations underlying the Texas Action have no basis in
fact and that this lawsuit is without merit. The Company has retained counsel
and is vigorously defending against these claims. The participants in the Texas
Action will be provided the opportunity to accept the settlement discussed
above. In addition, the Company participated in a mediation proceeding relating
to the Texas Action on October 23, 2001. During the six months ended December
31, 2001, the Company incurred and expensed legal fees associated with these
claims of approximately $525,000, however, an insurance claim for the aggregate
amount incurred in connection with the Texas Action in excess of applicable
deductibles has been filed by the Company. During the first quarter of fiscal
2002, one of the insurance companies responsible for the claim, which had
previously filed for reorganization, was declared insolvent. The Company is
working with regulatory agencies to resolve and collect the monies due under
this policy, although the Company currently considers any potential recovery
under this policy as speculative. Accordingly, no claim for recovery is recorded
as of December 31, 2001.

LightPath is subject to various other claims and lawsuits in the ordinary course
of its business, none of which are currently considered material to the
Company's financial condition and results of operations. Except as set forth
above, there have been no material developments in any legal actions reported in
the Company's Form 10-KSB for the year ended June 30, 2001.

11
LIGHTPATH TECHNOLOGIES, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS


MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS

THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES A SAFE HARBOR FOR
FORWARD LOOKING STATEMENTS MADE BY OR ON BEHALF OF THE COMPANY. ALL STATEMENTS
IN THIS "MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS" AND ELSEWHERE IN THIS REPORT, OTHER THAN STATEMENTS OF HISTORICAL
FACTS, WHICH ADDRESS ACTIVITIES, EVENTS OR DEVELOPMENTS THAT THE COMPANY EXPECTS
OR ANTICIPATES WILL OR MAY OCCUR IN THE FUTURE, INCLUDING SUCH THINGS AS FUTURE
CAPITAL EXPENDITURES, GROWTH, PRODUCT DEVELOPMENT, SALES, BUSINESS STRATEGY AND
OTHER SIMILAR MATTERS ARE FORWARD-LOOKING STATEMENTS. THESE FORWARD-LOOKING
STATEMENTS ARE BASED LARGELY ON THE COMPANY'S CURRENT EXPECTATIONS AND
ASSUMPTIONS AND ARE SUBJECT TO A NUMBER OF RISKS AND UNCERTAINTIES, MANY OF
WHICH ARE BEYOND THE COMPANY'S CONTROL. ACTUAL RESULTS COULD DIFFER MATERIALLY
FROM THE FORWARD-LOOKING STATEMENTS SET FORTH HEREIN AS A RESULT OF A NUMBER OF
FACTORS, INCLUDING, BUT NOT LIMITED TO, THE COMPANY'S EARLY STAGE OF
DEVELOPMENT, THE NEED FOR ADDITIONAL FINANCING, INTENSE COMPETITION IN VARIOUS
ASPECTS OF ITS BUSINESS AND OTHER RISKS DESCRIBED IN THE COMPANY'S REPORTS ON
FILE WITH THE SECURITIES AND EXCHANGE COMMISSION. IN LIGHT OF THESE RISKS AND
UNCERTAINTIES, ALL OF THE FORWARD-LOOKING STATEMENTS MADE HEREIN ARE QUALIFIED
BY THESE CAUTIONARY STATEMENTS AND THERE CAN BE NO ASSURANCE THAT THE ACTUAL
RESULTS OR DEVELOPMENTS ANTICIPATED BY THE COMPANY WILL BE REALIZED. THE COMPANY
UNDERTAKES NO OBLIGATION TO UPDATE OR REVISE ANY OF THE FORWARD LOOKING
STATEMENTS CONTAINED HEREIN.

ACQUISITIONS

GELTECH, INC.

On September 20, 2000, LightPath acquired all of the outstanding shares of
Geltech, Inc. (Geltech), a manufacturer of precision molded aspheric optics used
in the active telecommunication components markets, for an aggregate purchase
price of approximately $28.5 million. In the first quarter of fiscal 2001, the
Company recorded an immediate non-recurring charge of $9.1 million related to
the acquired in-process research and development of Geltech. The value assigned
to in-process research and development was determined by the Company based on
estimates of the projected discounted cash flows from certain development
projects including diffraction gratings, waveguides, lens arrays and
sub-assembly technologies. These programs were in various stages of completion
ranging from 30% to 50% of completion, with estimated completion dates through
December 2001 and projected costs to complete of approximately $2.25 million. As
of June 30, 2001 these programs were not complete and a new completion date of
June 2002 was established. Geltech had no sales in fiscal 2001 from these
programs which is consistent with the revenue projections.

Geltech had no sales during the six months ended December 31, 2001 from these
programs which is consistent with the revenue projections. During the second
quarter of fiscal 2002 the Company decided to defer the development of the
diffraction gratings and waveguides, projects which were in process at the
acquisition of Geltech, due primarily to the continued decline in the market for
telecommunications components. However, the development of the lens arrays and
sub-assembly technologies, projects also in process at the acquisition date,
continue as planned.

For fiscal 2002, the consolidated research and development expenditures budget
for LightPath was approximately $7.7 million, which includes approximately $1.7
million related to the ongoing development efforts which were in process at the
acquisition of Geltech. For the six months ended December 31, 2001, we estimate
approximately $630,000 of research and development expenditures were incurred in
connection with these efforts.

HORIZON PHOTONICS, INC.

On April 14, 2000, LightPath acquired Horizon Photonics, Inc. (Horizon), a
company engaged in the automated production of passive optical components for
the telecommunications and data communications markets, for a total purchase
price of approximately $40.2 million. In the fourth quarter of fiscal 2000, the
Company recorded an immediate non-recurring charge of $4.2 million, related to
the acquired in-process research and development of Horizon. The in-process
research and development related to micro-collimator products as well as active
alignment and isolator injection molding technologies that were under
development at the time of acquisition. These programs were in various stages of
completion ranging from 50% to 60%, with estimated completion dates through June
2001 and estimated costs to complete the projects of $1 million. As of June 30,
2001 these programs were not completed and a revised completion date of June
2002 was established. Horizon had no sales in fiscal 2001 from these programs
which is consistent with the revenue projections.

Horizon had no sales during the six months ended December 31, 2001 from these
programs which is consistent with the revenue projections.

12
LIGHTPATH TECHNOLOGIES, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS


For fiscal 2002, the consolidated research and development expenditures budget
for LightPath was approximately $7.7 million, which includes approximately $1.6
million related to the ongoing development efforts which were in process at the
acquisition of Horizon. For the six months ended December 31, 2001, we estimate
approximately $1 million of research and development expenditures were incurred
which included these efforts as well as other isolator developments efforts.

RESULTS OF OPERATIONS

THREE MONTHS ENDED DECEMBER 31, 2001 COMPARED TO THE THREE MONTHS ENDED DECEMBER
31, 2000

CONSOLIDATED OPERATIONS

Our consolidated revenues totaled $2.4 million for the second quarter of
fiscal 2002, a decrease of approximately $5.4 million or 69% compared to
revenues for the second quarter of fiscal 2001. The decrease was primarily
attributable to a decrease in telecom product sales of $4.4 million or 56% and a
decrease in traditional optics sales of $1 million or 13%.

In the second quarter of fiscal 2002, consolidated cost of sales was
approximately 159% of product sales, an increase from the comparable period of
fiscal 2001 which reported cost of sales of 61%. During the quarter the Company
recorded a write down of inventory of approximately $1.2 million. Excluding the
inventory write down, cost of sales during the quarter would have been
approximately 109%, an increase of 48% from the comparable period of fiscal 2001
due primarily to the underutilization of manufacturing facilities and staff
because of reduced sales of telecom and traditional optics products during the
quarter.

During the second quarter of fiscal 2002, sales declined approximately 30
percent from levels noted during the first quarter. The company also noted
several factors in its evaluation of the value of inventory during the quarter
which resulted in a charge of approximately $1.2 million to write down inventory
to net realizable value. The Company received a determination that certain
lenses and raw materials did not pass qualification requirements for their
particular applications during the quarter. In addition, the value of certain
finished lens had diminished due to a change in market conditions because a
competitor began reducing prices for similar products to a level below our cost.
Finally, the Company noted uncertainty regarding the realization of value for
certain finished products on hand for a recently cancelled purchase order.
Specifically, charges to write-down inventory of approximately $517,000,
$171,000 and $247,000 were recorded for finished goods, work in process and raw
materials, respectively. In addition, inventory write-off's of $220,000 were
recorded ($100,000 of finished goods and $120,000 of raw materials) and the
related inventory was disposed of in January 2002 as no alternative use was
identified.

During the second quarter of fiscal 2002, selling, general and
administrative costs decreased by $1.4 million from the second quarter of fiscal
2001 to $2.9 million, due primarily to a decrease of $1.3 million in
administration and manufacturing support personnel costs. We incurred several
non-cash charges during the second quarter of fiscal 2002, including an
impairment charge of approximately $7 million related to intangible assets and
manufacturing equipment, $2.4 million in amortization of goodwill and
intangibles from acquisitions, and $1.8 million in stock-based compensation
charges. The impairment consists of approximately $6.5 million related to the
values assigned to certain intangibles at acquisition during April and September
2000, which may not be recoverable due to reduced revenue forecasts from those
expected at acquisition as a result of the downturn in the telecom industry and
approximately $0.5 million due to the removal of excess manufacturing lines used
for collimator production. In addition, the Company reversed the net deferred
tax liability of approximately $3.3 million established in connection with the
non-taxable purchase of Geltech against the related intangible assets prior to
the impairment charge as the carrying value of the remaining Geltech intangible
assets was reduced in connection with the impairment.

Research and development costs increased by approximately $0.4 million to
$2.2 million in the second quarter of fiscal 2002 versus 2001. The majority of
development work consisted of expenses associated with automation development
and products in the areas of telecommunication switches, isolators and next
generation optical subassemblies, waveguides, lens arrays and sub-assembly
technologies.

13
LIGHTPATH TECHNOLOGIES, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS


Investment and other income decreased approximately $474,000 as interest
earned on investments in the second quarter of fiscal 2002 declined due to lower
interest rates and a decrease in cash balances. Interest and other expense in
the second quarter of fiscal 2002 and the comparable period of fiscal 2001 was
not significant.

Net loss of $17.6 million in the second quarter of fiscal 2002 includes
$11.2 million from the non-cash charges described above and $1.2 million related
to inventory write-offs, which if excluded, would have resulted in a net loss of
$5.2 million. As compared to the second quarter of fiscal 2001 which reported a
net loss of $8.9 million including $6.5 million in non-cash charges, which if
excluded, would have resulted in a net loss of $2.4 million. The $2.8 million
increase in net loss excluding the non-cash charges was due primarily to the
$5.4 million decrease in total revenues offset by the decreased cost of sales of
$2.1 million, and decreases in operating costs primarily in selling, general and
administrative expense which were offset by increased research and development
costs. Net loss applicable to common shareholders of $17.6 million for the
second quarter of fiscal 2002 included an additional charge of $22,407
attributable to the premium on our outstanding preferred stock. Net loss per
share of $0.91 in the second quarter of fiscal 2002 was an increase of $0.45
compared to the second quarter of fiscal 2001 net loss per share of $0.46. Net
loss applicable to common shareholders for the second quarter of fiscal 2001 of
$8.9 million included $18,551 attributable to the premium on the Company's
outstanding preferred stock.

Sales backlog does not represent sales, rather it is an indicator of
customer orders received by the Company. Sales revenues from orders will be
recognized in future quarters, generally nine to twelve months, as the products
are shipped. At December 31, 2001, our consolidated backlog was $4.4 million
consisting of $3.2 million in orders for telecom components and $1.2 million in
orders for lenses. During the second quarter the Company revised its policy for
disclosing sales backlog such that unscheduled orders or orders with a delivery
past 12 months would be excluded from the backlog, which caused the Company to
decrease reported backlog to $6.4 million from the previously disclosed sales
backlog of $16.5 million at September 30, 2001 which was comprised of $14.6
million in orders for telecom components and $1.9 million in orders for lenses.

TELECOM SEGMENT

For the second quarter of fiscal 2002, telecom product sales decreased 75%
to approximately $1.5 million from $5.8 million for the comparable period last
year. The telecom segment sales for fiscal 2002 include isolator sales of $0.6
million, $0.3 million of collimator product sales and $0.6 million of active
telecom components sales.

The telecom segment incurred an operating loss of $3.7 million for the
second quarter of fiscal 2002 as compared to a loss of $1.6 million for the
comparable period last year due primarily to decreased sales, lower margins and
inventory write-offs.

TRADITIONAL OPTICS SEGMENT

During the second quarter of fiscal 2002, our approximately $0.9 million of
segment sales were comprised of $0.7 million in finished lens product sales and
$0.2 million from laser optic lens sales, compared with $1.9 million for the
comparable period last year. The decrease of $1 million over the comparable
period of the prior year was due primarily to the reduced sales of optics
products used in data storage which accounted for approximately $1.7 million of
traditional optics sales for the second quarter of fiscal 2001.

The traditional optics segment incurred an operating loss of approximately
$1.1 million for the second quarter of fiscal 2002 as compared to operating
income of approximately $275,000 for the comparable period last year. The
increased loss during the quarter was primarily due to reduced sales,
unfavorable margins and inventory write-offs.

14
LIGHTPATH TECHNOLOGIES, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS


SIX MONTHS ENDED DECEMBER 31, 2001 COMPARED TO THE SIX MONTHS ENDED DECEMBER 31,
2000

CONSOLIDATED OPERATIONS

Our consolidated revenues totaled $5.8 million for the first six months of
fiscal 2002, a decrease of approximately $5 million or 46% compared to revenues
for the first six months of fiscal 2001. The decrease was primarily attributable
from a decrease in telecom product sales of $5.1 million or 47%, offset by 1% or
$0.1 million increase in traditional optics sales. Sales generated from the
acquired Geltech business (September 2000) accounted for $2.9 million or 49% of
the total revenue in fiscal 2002 as compared to $3.4 million or 32% of total
revenue for the comparable period of fiscal 2001.

In the first six months of fiscal 2002, consolidated cost of sales was 118%
of product sales, an increase from the comparable period last year which
reported cost of sales of 59%. During the second quarter the Company recorded a
write down of inventory of approximately $1.2 million. Excluding the inventory
write down, cost of sales during the quarter would have been approximately 98%,
an increase of 39% from the comparable period of fiscal 2001. Approximately 36%
of the increase was due to the reduction in sales for telecom products, and the
underutilization of manufacturing facilities and staff. In addition, in the
first quarter we determined that we were selling some traditional optic products
at a negative gross margin which impacted consolidated gross margins by
approximately 3%. To counter these cost overages we reduced the manufacturing
staff, eliminated unprofitable traditional optic products, and closed our
Auburn, California facility resulting in a total decrease in manufacturing
personnel of 37% since June 30, 2001. It is anticipated that these measures will
improve our cost of sales future quarters as we work to balance our
manufacturing capabilities and product lines, however, economic conditions may
result in pricing pressure in future quarters of fiscal 2002 which could reduce
margins.

During the six months ended December 31, 2001, total inventory declined 4%
from prior levels before consideration of the inventory write down recorded
during the second quarter of fiscal 2002. Raw materials continue to make up the
majority of our inventory at $2.5 million or 63% of total inventory. We have
approximately $2 million of raw materials on hand specifically used in the
production of isolators that have long lead times and the Company has elected to
maintain a sufficient quantity of these materials. Our inventory turn ratio was
2.9 times and 4.0 times for the six months ended December 31, 2001 and 2000,
respectively, which is indicative of the reduction in sales experienced in
fiscal 2002.

During the second quarter of fiscal 2002, sales declined approximately 30
percent from levels noted during the first quarter. The company also noted
several factors in its evaluation of the value of inventory during the quarter
which resulted in a charge of approximately $1.2 million to write down inventory
to net realizable value. The Company received a determination that certain
lenses and raw materials did not pass certain qualification requirements for
their particular applications during the quarter. In addition, the value of
certain finished lens had diminished due to a change in market conditions
because a competitor began reducing prices for similar products to a level below
our cost. Finally, the Company noted uncertainty regarding the realization of
value for certain finished products on hand for a recently cancelled purchase
order. Specifically, charges to write-down inventory of approximately $517,000,
$171,000 and $247,000 were recorded related to finished goods, work in process
and raw materials, respectively. In addition, inventory write-off's of $220,000
were recorded ($100,000 of finished goods and $120,000 of raw materials) and the
related inventory was disposed of in January 2002 as no alternative use was
identified.

During the first six months of fiscal 2002, selling, general and
administrative costs decreased by $1 million from first the six months of fiscal
2001 to $6.7 million, even after including $1.4 million accrued for legal fees
and the proposed litigation settlement, and $0.5 million of administrative costs
incurred by Geltech. These increases were offset by a decrease of $2.7 million
in administration and manufacturing support personnel costs. We incurred several
non-cash charges during the first six months of fiscal 2002, including an
impairment charge of $7 million related to intangible assets and manufacturing
equipment, $5.1 million in amortization of goodwill and intangibles from
acquisitions, and $4.7 million in stock-based compensation charges. In addition,
the Company reversed the net deferred tax liability of approximately $3.3
million established in connection with the non-taxable purchase of Geltech
against the related intangible assets prior to the impairment charge as the
carrying value of the remaining Geltech intangible assets was reduced in
connection with the impairment.

Research and development costs increased by approximately $1.1 million to
$4.2 million in the first six months of fiscal 2002 versus fiscal 2001 of which
$0.3 million was due to Geltech. The majority of development work consisted of
expenses associated with automation development and products in the areas of
telecommunication switches, isolators and next generation optical subassemblies,
waveguides, lens arrays and sub-assembly technologies. In an effort to control
research and development costs, the Company has reduced development staff

15
LIGHTPATH TECHNOLOGIES, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS


levels, deferred any additional effort on the switch project and is in the
process of subleasing the New Jersey development facility.

Investment and other income included a non-recurring gain of approximately
$390,000 related to the first quarter sale of certain assets located in Auburn,
CA, while interest earned on investments decreased approximately $971,000 during
the first six months of fiscal 2002 as a result of lower interest rates and a
decrease in cash balances. Interest expense in during the first six months of
fiscal 2002 and the comparable period of fiscal 2001 was not significant.

Net loss of $28 million in the first six months of fiscal 2002 includes
$16.8 million from the non-cash charges described above, $1.4 million related to
litigation settlement costs and $1.2 million for inventory write-offs, which if
excluded, would have resulted in a net loss of $8.6 million. As compared to the
first six months of fiscal 2001 which reported a net loss of $25.8 million
including $20.8 million in non-cash charges, which if excluded, would have
resulted in a net loss of $5 million. The $3.6 million increase in net loss
excluding the non-cash charges was due primarily to the $5 million decrease in
total revenues, offset by decreased cost of sales of $0.7 million while
decreases in operating costs primarily in selling, general and administrative
expense were offset by increased research and development costs. Net loss
applicable to common shareholders of $28 million for the first six months of
fiscal 2002 included an additional charge of $48,016 attributable to the premium
on our outstanding preferred stock. Net loss per share of $1.45 in the first six
months of fiscal 2002 was an increase of $0.07 compared to the first six months
of fiscal 2001 net loss per share of $1.38. Net loss applicable to common
shareholders for the first six months of fiscal 2001 of $25.8 million included
$45,464 attributable to the premium on the Company's outstanding preferred
stock.

TELECOM SEGMENT

For the first six months of fiscal 2002, telecom product sales decreased
59% to approximately $3.5 million from $8.6 million for the comparable period
last year. The telecom segment sales in the first six months of fiscal 2002
include isolator sales of $1.8 million, $0.7 million of collimator product sales
and $1 million of active telecom components sales.

The telecom segment incurred an operating loss of $6.2 million for the
first six months of fiscal 2002 as compared to a loss of $3.4 million for the
comparable period last year due primarily to decreased sales, reduced margins
due to underutilization of capacity, inventory write-offs and increased research
and development costs associated with the switch project.

The decrease in telecom sales for the first six months together with the
flat to down sales backlog reflect the general market condition for optical
components and the broader telecommunications sector. We continue to work
closely with our customers to manage excess inventory levels as well as focus
with them on next generation products. During the first six months, our work on
next generation systems led to design wins and corresponding orders but overall
spending levels are currently restrained. We have implemented processes built
around automated platforms that are resulting in significant yield improvements
that we believe are unmatched in the photonics industry. We have also been able
to maintain robust design activity throughout most of this downturn which we
attribute to the reliability of our products demonstrated by the completion of
full Telcordia qualifications during the first quarter of fiscal 2002. It is our
belief that the photonics industry will begin to mature as the industry moves
out of this downturn and that there will be less focus on rapid capacity
expansion and more focus on manufacturing and process issues. Specifically, we
believe attention will shift to the implementation of highly automated
manufacturing processes and yield improvements where we believe we have a
significant advantage.

TRADITIONAL OPTICS SEGMENT

During the first six months of fiscal 2002, our approximately $2.3 million
of segment sales were comprised of $1.8 million in finished lens products and
$0.5 million from laser optic lens sales, compared with $2.2 million for the
comparable period last year. During the first quarter of 2002, we have stopped
manufacturing several product lines, including data storage lenses due to
unfavorable margins. In addition, due to the closure of the Auburn, CA facility
we consolidated the manufacturing of all finished lens products into the
Orlando, FL facility.

16
LIGHTPATH TECHNOLOGIES, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS


The traditional optics segment incurred an operating loss of approximately
$1.8 million for the first six months of fiscal 2002 as compared to an operating
loss of approximately $42,000 for the comparable period last year. The increased
loss was primarily due to reduced sales, unfavorable margins and inventory
write-offs we incurred during the first six months of fiscal 2002.

LIQUIDITY AND CAPITAL RESOURCES

We financed our initial operations through private placements of equity and
debt until February 1996 when our initial public offering of units of common
stock and Class A and B Warrants generated net proceeds of approximately $7.2
million. From June 1997 through November 1999, we completed four preferred stock
and one convertible debt private placements which generated total net proceeds
of approximately $12 million. During fiscal 2000 and 2001, we received net
proceeds of approximately $67.6 million from the exercise of stock options and
warrants issued at the initial public offering or in connection with previous
private placements. While the Company has no firm commitments for any future
financing at this time, management believes that its financial resources will be
sufficient to finance the Company's operations and capital expenditures,
excluding acquisitions, for the next twelve months.

Cash used in operations for the six months ended December 31, 2001, was
approximately $6.7 million, a decrease of approximately $2.9 million from the
same period of fiscal 2001. Working capital needs declined due to the
maintenance of accounts receivable and inventory balances and the accrual of
certain settlement costs which were not paid as of December 31, 2001. We expect
to continue to incur net losses until such time, if ever, as we obtain market
acceptance for our products at sale prices and volumes which provide adequate
gross revenues to offset our operating costs. During six months ended December
31, 2001, we expended approximately $2.4 million for capital equipment and
patent protection, offset by proceeds from the sale of assets of approximately
$0.4 million. The majority of the capital expenditures during the year were
related to the equipment used to enhance or expand our manufacturing facilities.
An additional $0.8 million has been budgeted in fiscal 2002 to for various
manufacturing and development projects. An additional approximately $1.6 million
of cash would be expended if all of the holders of Class E Common Stock selected
cash for the settlement offer in the Delaware action.

RECENT ACCOUNTING PRONOUNCEMENTS

On October 3, 2001 the FASB issued Statement No. 144, "Accounting for the
Impairment or Disposal of Long-Lived Assets," which addresses financial
accounting and reporting for the impairment or disposal of long-lived assets.
SFAS 144 supercedes SFAS 121, "Accounting for the Impairment of Long-Lived
Assets and for Long-Lived Assets to Be Disposed Of," but retains many of the
fundamental provisions of SFAS 121. SFAS 144 also supercedes APB Opinion No. 30,
"Reporting the Results of Operations, Reporting the Effects of Disposal of a
Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring
Events and Transactions." SFAS 144 retains the requirement in Opinion 30 to
report separately discontinued operations and extends that reporting to a
component of an entity that either has been disposed of or is classified as held
for sale. SFAS 144 is effective for fiscal years beginning after December 15,
2001 and interim periods within those fiscal years. Early application is
permitted. LightPath does not expect the adoption of SFAS 144 to have a material
impact on its financial statements or results of operations.

In June 2001, the FASB issued Statement No. 143, ACCOUNTING FOR ASSET
RETIREMENT OBLIGATIONS, which addresses financial accounting and reporting for
obligations associated with the retirement of tangible long-lived assets and the
associated asset retirement costs. The standard applies to legal obligations
associated with the retirement of long-lived assets that result from the
acquisition, construction, development and (or) normal use of the asset.
Statement No. 143 requires that the fair value of a liability for an asset
retirement obligation be recognized in the period in which it is incurred if a
reasonable estimate of fair value can be made. The fair value of the liability
is added to the carrying amount of the associated asset and this additional
carrying amount is depreciated over the life of the asset. The liability is
accreted at the end of each period through charges to operating expense. If the
obligation is settled for other than the carrying amount of the liability, the
Company will recognize a gain or loss on settlement. The Company is required and
plans to adopt the provisions of Statement No. 143 for the quarter ending
December 31, 2002. To accomplish this, the Company must identify all legal
obligations for asset retirement obligations, if any, and determine the fair
value of these obligations on the date of adoption. The determination of fair

17
LIGHTPATH TECHNOLOGIES, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS


value is complex and will require the Company to gather market information and
develop cash flow models. Additionally, the Company will be required to develop
processes to track and monitor these obligations. Because of the effort
necessary to comply with the adoption of Statement No. 143, it is not
practicable for management to estimate the impact of adopting this Statement at
the date of this report.

In June 2001, the FASB issued Statement No. 141, BUSINESS COMBINATIONS, and
Statement No. 142, GOODWILL AND OTHER INTANGIBLE ASSETS. Statement 141 requires
that the purchase method of accounting be used for all business combinations
initiated after June 30, 2001 as well as all purchase method business
combinations completed after June 30, 2001. Statement 141 also specifies
criteria intangible assets acquired in a purchase method business combination
must meet to be recognized and reported apart from goodwill. Statement 142 will
require that goodwill and intangible assets with indefinite useful lives no
longer be amortized, but instead be tested for impairment at least annually in
accordance with the provisions of Statement 142. Statement 142 will also require
that intangible assets with estimable useful lives be amortized over their
respective estimated useful lives to their estimated residual values, if any,
and reviewed for impairment in accordance with FAS Statement No. 121, ACCOUNTING
FOR THE IMPAIRMENT OF LONG-LIVED ASSETS AND FOR LONG-LIVED ASSETS TO BE DISPOSED
OF.

The Company is required to adopt the provisions of Statement 141 on July 1,
2002. The Company had no business combinations initiated prior to July 1, 2001.
Goodwill and intangible assets acquired in business combinations completed
before July 1, 2001 will continue to be amortized and tested for impairment in
accordance with the appropriate pre-Statement 142 accounting requirements prior
to the adoption of Statement 142.

Statement 141 will require, upon adoption of Statement 142, that the
Company evaluate its existing intangible assets and goodwill that were acquired
in a prior purchase business combinations, and to make any necessary
reclassifications in order to conform with the new criteria in Statement 141 for
recognition apart from goodwill. Upon adoption of Statement 142, the Company
will be required to reassess the useful lives and residual values of all
intangible assets acquired, and make any necessary amortization period
adjustments by the end of the first interim period after adoption. In addition,
to the extent an intangible asset is identified as having an indefinite useful
life, the Company will be required to test the intangible asset for impairment
in accordance with the provisions of Statement 142 within the first interim
period. Any impairment loss will be measured as of the date of adoption and
recognized as the cumulative effect of a change in accounting principle in the
first interim period.

In connection with Statement 142's transitional goodwill impairment
evaluation, the Statement will require the Company to perform an assessment of
whether there is an indication that goodwill is impaired as of the date of
adoption. To accomplish this, the Company must identify its reporting units and
determine the carrying value of each reporting unit by assigning the assets and
liabilities, including the existing goodwill and intangible assets, to those
reporting units as of the date of adoption. The Company will then have up to six
months from the date of adoption to determine the fair value of each reporting
unit and compare it to the reporting unit's carrying amount. To the extent a
reporting unit's carrying amount exceeds its fair value, an indication exists
that the reporting unit's goodwill may be impaired and the Company must perform
the second step of the transitional impairment test. In the second step, the
Company must compare the implied fair value of the reporting unit's goodwill,
determined by allocating the reporting unit's fair value to all of it assets
(recognized and unrecognized) and liabilities in a manner similar to a purchase
price allocation in accordance with Statement 141, to its carrying amount, both
of which would be measured as of the date of adoption. This second step is
required to be completed as soon as possible, but no later than the end of the
year of adoption. Any transitional impairment loss will be recognized as the
cumulative effect of a change in accounting principle in the Company's statement
of earnings.

The Company expects to have unamortized goodwill of approximately $2.3
million remaining at July 1, 2002, which will be subject to the transition
provisions of Statements 141 and 142. Amortization expense related to goodwill
was $2.95 million for the year ended June 30, 2001. Because of the extensive
effort needed to comply with adopting Statements 141 and 142, it is not
practicable to reasonably estimate the impact of adopting these Statements on
the Company's financial statements at the date of this report, including whether
it will be required to recognize any transitional impairment losses as the
cumulative effect of a change in accounting principle.

18
LIGHTPATH TECHNOLOGIES, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS


QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company invests liquid cash primarily in money market accounts,
certificates of deposit or in overnight repurchase agreements. Due to the
short-term nature of these investments, we believe that the market risk related
to these investments is minimal.

19
LIGHTPATH TECHNOLOGIES, INC.


PART II

ITEM 1. LEGAL PROCEEDINGS

On May 2, 2000, the Company commenced a class action lawsuit in the
Chancery Court of Delaware, New Castle County. The action seeks a declaratory
judgment with respect to the Company's right to redeem the Class E Common Stock
on December 30, 2000 for $.0001 per share, the right of the holders of Class E
Common Stock to vote at the Annual Meeting held on October 6, 2000, and for
certification of the holders of Class E Common Stock as a class and the named
defendants as its representatives. The named defendants are Donald E. Lawson,
former President, Chief Executive Officer and Director of the Company, who owns
an aggregate of 25,000 shares of Class E Common Stock, Louis G. Leeburg,
Director of the Company, who owns an aggregate of 7,272 shares of Class E Common
Stock, and William Leeburg, who owns or controls an aggregate of 21,816 shares
of Class E Common Stock. The Company proposed a settlement of this lawsuit which
the Delaware Chancery Court heard on January 8, 2001. The settlement proposal
was made to include all holders of Class E Common Stock. On February 2, 2001,
the Delaware Chancery Court issued a letter in which it indicated that holders
of Class E Common Stock must be provided an opportunity to request exclusion
from the settlement class. The Company has re-evaluated the proposed settlement
offer in December 2001 determined it will proceed with the settlement to include
a provision that each E shareholder has the right to request exclusion from the
settlement class. The final settlement terms allow the holders of Class E Common
Stock to elect to receive either $0.40 for each share of Class E Common Stock or
receive an option to purchase five shares of Class A Common Stock for each 100
shares of Class E Common Stock they hold for a period of two years with an
exercise price of $3.73 per share. The Company estimates that if all of the
Class E Common Stock were exchanged for options, approximately 40,220 options to
acquire 201,102 shares of Class A Common Stock would be issued resulting in a
settlement charge equal to the fair value of the options issued of approximately
$458,000. If all of the Class E Common Stock were exchanged for cash, a
settlement charge of approximately $1.6 million would be recorded. The Company
has determined that it is probable that the settlement offer will occur and an
estimated settlement charge of $1.1 million has been accrued as of December 31,
2001.

On or about June 9, 2000, a small group of holders of Class E Common Stock
(the "Texas Plaintiffs") commenced an action in a state court in Texas (the
"Texas Action"). The Texas Plaintiffs allege that the actions of the Company,
and certain named individuals, leading up to and surrounding the Company's 1995
proxy statement constitute fraud, negligent misrepresentation, fraudulent
inducement, breach of fiduciary duty and civil conspiracy. In general, the Texas
Plaintiffs allege misrepresentations and omissions in connection with a request
from the Company that its shareholders consent to a recapitalization, resulting
in a 5.5 to 1 reverse stock split and the issuance of certain Class E Common
Stock. The Texas Plaintiffs further allege that, as a result of the defendants'
actions, they were induced to consent to the Company's recapitalization. The
Company believes the allegations underlying the Texas Action have no basis in
fact and that this lawsuit is without merit. The Company has retained counsel
and is vigorously defending against these claims. The participants in the Texas
Action will be provided the opportunity to accept the settlement discussed
above. In addition, the Company participated in a mediation proceeding relating
to the Texas Action on October 23, 2001. During the six months ended December
31, 2001, the Company incurred and expensed legal fees associated with these
claims of approximately $525,000, however, an insurance claim for the aggregate
amount incurred in connection with the Texas Action in excess of applicable
deductibles has been filed by the Company. During the first quarter of fiscal
2002, one of the insurance companies responsible for the claim, which had
previously filed for reorganization, was declared insolvent. The Company is
working with regulatory agencies to resolve and collect the monies due under
this policy, although the Company currently considers any potential recovery
under this policy as speculative. Accordingly, no claim for recovery is recorded
as of December 31, 2001.

LightPath is subject to various other claims and lawsuits in the ordinary
course of its business, none of which are currently considered material to the
Company's financial condition and results of operations. Except as set forth
above, there have been no material developments in any legal actions reported in
the Company's Form 10-KSB for the year ended June 30, 2001.

20
LIGHTPATH TECHNOLOGIES, INC.


ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS

LightPath Technologies, Inc. conducted its 2001 Annual Meeting of
Stockholders on October 17, 2001. Actions concluded at the meeting through
submission of matters to a vote by stockholders was conducted by proxy and
included the following:

1. Election of Class I Directors to hold office until the Annual Meeting
of Stockholders in 2004 a Class II Director to hold office until the
Annual Meeting of Stockholders in 2003. The election of Class I
Directors, Robert Ripp and Robert Bruggeworth, of the Company was
approved by a vote of Class A shareholders of 17,605,832 FOR and
79,631 WITHHOLD AUTHORITY. The election of Class II Director Steve
Brueck, of the Company was approved by a vote of Class A shareholders
of 17,617,932 FOR and 67,531 WITHHOLD AUTHORITY. The terms of the
Company's Class III Directors, Donald Lawson and Louis Leeburg and of
its Class II Directors, James Adler Jr. continued after the date of
the Annual Meeting.

2. Ratification of the selection of KPMG LLP as independent accountants
for the Company for the fiscal year ending June 30, 2002 was approved
by a vote of Class A shareholders 17,640,658 FOR; 19,147 AGAINST and
24,658 ABSTENTIONS.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None

ITEM 5. OTHER INFORMATION

Donald Lawson, President and CEO resigned from the Company in October 2002
to pursue other interests. He will receive severance compensation per the terms
of his employment contract of approximately $500,000. Robert Ripp, Chairman of
the Board of Directors, was elected to serve as interim President and CEO and a
search committee was formed by the Board of Directors to fill this position. Mr.
Ripp receives a monthly consulting fee of approximately $21,000 while acting as
the interim President and CEO. Mr. Ripp also received an incentive stock option
on October 31, 2001, for 100,000 shares of common stock which was fully vested
at issuance, has a term of ten years, and was priced at $2.78 per share which
was the fair market value of the underlying stock on the grant date.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

a) Exhibits

None

b) The following reports on Form 8-K were filed under the Securities Exchange
Act of 1934 during the quarter ended December 31, 2001:

1. Current report on Form 8-K dated October 1, 2001, announced the first
quarter of fiscal 2001 conference call would be held on October 25,
2001.
2. Current report on Form 8-K dated October 25, 2001, included the press
release of the first quarter of fiscal 2002 financial results.

21
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Report to be signed in its behalf by the
undersigned, thereunto duly authorized.


LIGHTPATH TECHNOLOGIES, INC.


By: /s/ Donna Bogue February 14, 2002
-------------------------------------------
DONNA BOGUE DATE
CHIEF FINANCIAL OFFICER

22